Loading…
Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial
Background. People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV) infection. However, PWID are considered “difficult to treat,” requiring a specifically adapted treatment setting, including psychosocial support. Methods. In this prospective, German trial, the impact of psy...
Saved in:
Published in: | Clinical infectious diseases 2013-08, Vol.57 (suppl_2), p.S97-S104 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c373t-7ad8e02a5f6c72f8dd63156cfaa08606b14031ad95da1a3474e19c362e3611853 |
---|---|
cites | cdi_FETCH-LOGICAL-c373t-7ad8e02a5f6c72f8dd63156cfaa08606b14031ad95da1a3474e19c362e3611853 |
container_end_page | S104 |
container_issue | suppl_2 |
container_start_page | S97 |
container_title | Clinical infectious diseases |
container_volume | 57 |
creator | Reimer, Jens Schmidt, Christiane Sybille Schulte, Bernd Gansefort, Dirk Gölz, Jörg Gerken, Guido Scherbaum, Norbert Verthein, Uwe Backmund, Markus |
description | Background. People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV) infection. However, PWID are considered “difficult to treat,” requiring a specifically adapted treatment setting, including psychosocial support. Methods. In this prospective, German trial, the impact of psychoeducation (PE) on retention and sustained virologic response (SVR) during HCV therapy among PWID was evaluated. We included 198 patients in opiate substitution therapy, who fulfilled indications for antiviral treatment. All patients received pegylated interferon alfa-2a and ribavirin therapy. Patients in the intervention group (n = 82) received manualized PE sessions. Results. In patients with HCV genotype 1 or 4 (GT 1/4), PE was associated with increased treatment completion (76% vs 55%, P = .038), whereas PE had no such effect among GT 2/3 patients, who showed fewer dropouts and higher SVR rates. Among GT 1/4 patients, a minimum of 5 PE sessions was associated with increased SVR (71% vs 48%, P = .037). Multivariate regression analyses confirmed the impact of PE in GT 1/4 and revealed further predictors for retention and SVR, such as preexisting mental distress and adverse events. Conclusions. In patients with a higher risk of dropout due to GT 1/4 or mental distress, PE was shown to improve retention and SVR. PE is an effective supportive intervention for intervention for HCV therapy among PWID. Clinical Trials Registration. NCT00844272. |
doi_str_mv | 10.1093/cid/cit307 |
format | article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1417528725</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>23484004</jstor_id><sourcerecordid>23484004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-7ad8e02a5f6c72f8dd63156cfaa08606b14031ad95da1a3474e19c362e3611853</originalsourceid><addsrcrecordid>eNpdkc1rFTEUxUOptLW6cW8JuBFxNJl8Pnfl-dFCSwu-uh3ykjs2j5nJmI_C2_uHm_pakS4uueT8csjhIPSKkg-ULNhH612dzIjaQ0dUMNVIsaD7dSdCN1wzfYiep7QhhFJNxAE6bJnWnCh2hH5fp629DeCKNdmHCZ-Pcwx3kPAZzPUm-4SX-IePJeFVBJNHmDL-XKKffuKr2Qfv8PeyTpUsf9-vbiGaefsJn-JlmHIMwwDuPb6OIc1gs78DfFmG7G31gVg9vRleoGe9GRK8fDiP0c3XL6vlWXNx9e18eXrRWKZYbpRxGkhrRC-tanvtnGRUSNsbQ7Qkck05YdS4hXCGGsYVB7qwTLbAZE0u2DF6u_OtEX8VSLkbfbIwDGaCUFJHOVWi1aq9R988QTehxKn-rqOCS0G0ULJS73aUrfFShL6box9N3HaUdPfddLWbbtdNhU8eLMt6BPcPfSyjAq93wCblEP_TedUJZ38ANEWVuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1546508576</pqid></control><display><type>article</type><title>Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford Journals Online</source><creator>Reimer, Jens ; Schmidt, Christiane Sybille ; Schulte, Bernd ; Gansefort, Dirk ; Gölz, Jörg ; Gerken, Guido ; Scherbaum, Norbert ; Verthein, Uwe ; Backmund, Markus</creator><creatorcontrib>Reimer, Jens ; Schmidt, Christiane Sybille ; Schulte, Bernd ; Gansefort, Dirk ; Gölz, Jörg ; Gerken, Guido ; Scherbaum, Norbert ; Verthein, Uwe ; Backmund, Markus</creatorcontrib><description>Background. People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV) infection. However, PWID are considered “difficult to treat,” requiring a specifically adapted treatment setting, including psychosocial support. Methods. In this prospective, German trial, the impact of psychoeducation (PE) on retention and sustained virologic response (SVR) during HCV therapy among PWID was evaluated. We included 198 patients in opiate substitution therapy, who fulfilled indications for antiviral treatment. All patients received pegylated interferon alfa-2a and ribavirin therapy. Patients in the intervention group (n = 82) received manualized PE sessions. Results. In patients with HCV genotype 1 or 4 (GT 1/4), PE was associated with increased treatment completion (76% vs 55%, P = .038), whereas PE had no such effect among GT 2/3 patients, who showed fewer dropouts and higher SVR rates. Among GT 1/4 patients, a minimum of 5 PE sessions was associated with increased SVR (71% vs 48%, P = .037). Multivariate regression analyses confirmed the impact of PE in GT 1/4 and revealed further predictors for retention and SVR, such as preexisting mental distress and adverse events. Conclusions. In patients with a higher risk of dropout due to GT 1/4 or mental distress, PE was shown to improve retention and SVR. PE is an effective supportive intervention for intervention for HCV therapy among PWID. Clinical Trials Registration. NCT00844272.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/cit307</identifier><identifier>PMID: 23884073</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Adolescent ; Adult ; Aged ; Antiviral Agents - administration & dosage ; Antiviral drugs ; Behavior Therapy - methods ; Clinical trials ; Drug therapy ; Female ; Germany ; Hepatitis ; Hepatitis C ; Hepatitis C - drug therapy ; Humans ; Interferon-alpha - administration & dosage ; Male ; Medical treatment ; Medication Adherence ; Middle Aged ; Narcotics ; Opiate Substitution Treatment - methods ; Polyethylene Glycols - administration & dosage ; Prospective Studies ; Recombinant Proteins - administration & dosage ; Ribavirin - administration & dosage ; Substance Abuse, Intravenous - complications ; Substance Abuse, Intravenous - drug therapy ; Treatment Outcome ; Viral Load ; Young Adult</subject><ispartof>Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S97-S104</ispartof><rights>Copyright Oxford University Press, UK Aug 15, 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-7ad8e02a5f6c72f8dd63156cfaa08606b14031ad95da1a3474e19c362e3611853</citedby><cites>FETCH-LOGICAL-c373t-7ad8e02a5f6c72f8dd63156cfaa08606b14031ad95da1a3474e19c362e3611853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/23484004$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/23484004$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23884073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reimer, Jens</creatorcontrib><creatorcontrib>Schmidt, Christiane Sybille</creatorcontrib><creatorcontrib>Schulte, Bernd</creatorcontrib><creatorcontrib>Gansefort, Dirk</creatorcontrib><creatorcontrib>Gölz, Jörg</creatorcontrib><creatorcontrib>Gerken, Guido</creatorcontrib><creatorcontrib>Scherbaum, Norbert</creatorcontrib><creatorcontrib>Verthein, Uwe</creatorcontrib><creatorcontrib>Backmund, Markus</creatorcontrib><title>Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>Background. People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV) infection. However, PWID are considered “difficult to treat,” requiring a specifically adapted treatment setting, including psychosocial support. Methods. In this prospective, German trial, the impact of psychoeducation (PE) on retention and sustained virologic response (SVR) during HCV therapy among PWID was evaluated. We included 198 patients in opiate substitution therapy, who fulfilled indications for antiviral treatment. All patients received pegylated interferon alfa-2a and ribavirin therapy. Patients in the intervention group (n = 82) received manualized PE sessions. Results. In patients with HCV genotype 1 or 4 (GT 1/4), PE was associated with increased treatment completion (76% vs 55%, P = .038), whereas PE had no such effect among GT 2/3 patients, who showed fewer dropouts and higher SVR rates. Among GT 1/4 patients, a minimum of 5 PE sessions was associated with increased SVR (71% vs 48%, P = .037). Multivariate regression analyses confirmed the impact of PE in GT 1/4 and revealed further predictors for retention and SVR, such as preexisting mental distress and adverse events. Conclusions. In patients with a higher risk of dropout due to GT 1/4 or mental distress, PE was shown to improve retention and SVR. PE is an effective supportive intervention for intervention for HCV therapy among PWID. Clinical Trials Registration. NCT00844272.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antiviral Agents - administration & dosage</subject><subject>Antiviral drugs</subject><subject>Behavior Therapy - methods</subject><subject>Clinical trials</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Germany</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Hepatitis C - drug therapy</subject><subject>Humans</subject><subject>Interferon-alpha - administration & dosage</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Medication Adherence</subject><subject>Middle Aged</subject><subject>Narcotics</subject><subject>Opiate Substitution Treatment - methods</subject><subject>Polyethylene Glycols - administration & dosage</subject><subject>Prospective Studies</subject><subject>Recombinant Proteins - administration & dosage</subject><subject>Ribavirin - administration & dosage</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Substance Abuse, Intravenous - drug therapy</subject><subject>Treatment Outcome</subject><subject>Viral Load</subject><subject>Young Adult</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpdkc1rFTEUxUOptLW6cW8JuBFxNJl8Pnfl-dFCSwu-uh3ykjs2j5nJmI_C2_uHm_pakS4uueT8csjhIPSKkg-ULNhH612dzIjaQ0dUMNVIsaD7dSdCN1wzfYiep7QhhFJNxAE6bJnWnCh2hH5fp629DeCKNdmHCZ-Pcwx3kPAZzPUm-4SX-IePJeFVBJNHmDL-XKKffuKr2Qfv8PeyTpUsf9-vbiGaefsJn-JlmHIMwwDuPb6OIc1gs78DfFmG7G31gVg9vRleoGe9GRK8fDiP0c3XL6vlWXNx9e18eXrRWKZYbpRxGkhrRC-tanvtnGRUSNsbQ7Qkck05YdS4hXCGGsYVB7qwTLbAZE0u2DF6u_OtEX8VSLkbfbIwDGaCUFJHOVWi1aq9R988QTehxKn-rqOCS0G0ULJS73aUrfFShL6box9N3HaUdPfddLWbbtdNhU8eLMt6BPcPfSyjAq93wCblEP_TedUJZ38ANEWVuA</recordid><startdate>20130815</startdate><enddate>20130815</enddate><creator>Reimer, Jens</creator><creator>Schmidt, Christiane Sybille</creator><creator>Schulte, Bernd</creator><creator>Gansefort, Dirk</creator><creator>Gölz, Jörg</creator><creator>Gerken, Guido</creator><creator>Scherbaum, Norbert</creator><creator>Verthein, Uwe</creator><creator>Backmund, Markus</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T7</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20130815</creationdate><title>Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial</title><author>Reimer, Jens ; Schmidt, Christiane Sybille ; Schulte, Bernd ; Gansefort, Dirk ; Gölz, Jörg ; Gerken, Guido ; Scherbaum, Norbert ; Verthein, Uwe ; Backmund, Markus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-7ad8e02a5f6c72f8dd63156cfaa08606b14031ad95da1a3474e19c362e3611853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antiviral Agents - administration & dosage</topic><topic>Antiviral drugs</topic><topic>Behavior Therapy - methods</topic><topic>Clinical trials</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Germany</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Hepatitis C - drug therapy</topic><topic>Humans</topic><topic>Interferon-alpha - administration & dosage</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Medication Adherence</topic><topic>Middle Aged</topic><topic>Narcotics</topic><topic>Opiate Substitution Treatment - methods</topic><topic>Polyethylene Glycols - administration & dosage</topic><topic>Prospective Studies</topic><topic>Recombinant Proteins - administration & dosage</topic><topic>Ribavirin - administration & dosage</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Substance Abuse, Intravenous - drug therapy</topic><topic>Treatment Outcome</topic><topic>Viral Load</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reimer, Jens</creatorcontrib><creatorcontrib>Schmidt, Christiane Sybille</creatorcontrib><creatorcontrib>Schulte, Bernd</creatorcontrib><creatorcontrib>Gansefort, Dirk</creatorcontrib><creatorcontrib>Gölz, Jörg</creatorcontrib><creatorcontrib>Gerken, Guido</creatorcontrib><creatorcontrib>Scherbaum, Norbert</creatorcontrib><creatorcontrib>Verthein, Uwe</creatorcontrib><creatorcontrib>Backmund, Markus</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reimer, Jens</au><au>Schmidt, Christiane Sybille</au><au>Schulte, Bernd</au><au>Gansefort, Dirk</au><au>Gölz, Jörg</au><au>Gerken, Guido</au><au>Scherbaum, Norbert</au><au>Verthein, Uwe</au><au>Backmund, Markus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2013-08-15</date><risdate>2013</risdate><volume>57</volume><issue>suppl_2</issue><spage>S97</spage><epage>S104</epage><pages>S97-S104</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>Background. People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV) infection. However, PWID are considered “difficult to treat,” requiring a specifically adapted treatment setting, including psychosocial support. Methods. In this prospective, German trial, the impact of psychoeducation (PE) on retention and sustained virologic response (SVR) during HCV therapy among PWID was evaluated. We included 198 patients in opiate substitution therapy, who fulfilled indications for antiviral treatment. All patients received pegylated interferon alfa-2a and ribavirin therapy. Patients in the intervention group (n = 82) received manualized PE sessions. Results. In patients with HCV genotype 1 or 4 (GT 1/4), PE was associated with increased treatment completion (76% vs 55%, P = .038), whereas PE had no such effect among GT 2/3 patients, who showed fewer dropouts and higher SVR rates. Among GT 1/4 patients, a minimum of 5 PE sessions was associated with increased SVR (71% vs 48%, P = .037). Multivariate regression analyses confirmed the impact of PE in GT 1/4 and revealed further predictors for retention and SVR, such as preexisting mental distress and adverse events. Conclusions. In patients with a higher risk of dropout due to GT 1/4 or mental distress, PE was shown to improve retention and SVR. PE is an effective supportive intervention for intervention for HCV therapy among PWID. Clinical Trials Registration. NCT00844272.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>23884073</pmid><doi>10.1093/cid/cit307</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1058-4838 |
ispartof | Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S97-S104 |
issn | 1058-4838 1537-6591 |
language | eng |
recordid | cdi_proquest_miscellaneous_1417528725 |
source | JSTOR Archival Journals and Primary Sources Collection; Oxford Journals Online |
subjects | Adolescent Adult Aged Antiviral Agents - administration & dosage Antiviral drugs Behavior Therapy - methods Clinical trials Drug therapy Female Germany Hepatitis Hepatitis C Hepatitis C - drug therapy Humans Interferon-alpha - administration & dosage Male Medical treatment Medication Adherence Middle Aged Narcotics Opiate Substitution Treatment - methods Polyethylene Glycols - administration & dosage Prospective Studies Recombinant Proteins - administration & dosage Ribavirin - administration & dosage Substance Abuse, Intravenous - complications Substance Abuse, Intravenous - drug therapy Treatment Outcome Viral Load Young Adult |
title | Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A47%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psychoeducation%20Improves%20Hepatitis%20C%20Virus%20Treatment%20During%20Opioid%20Substitution%20Therapy:%20A%20Controlled,%20Prospective%20Multicenter%20Trial&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Reimer,%20Jens&rft.date=2013-08-15&rft.volume=57&rft.issue=suppl_2&rft.spage=S97&rft.epage=S104&rft.pages=S97-S104&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/cit307&rft_dat=%3Cjstor_proqu%3E23484004%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c373t-7ad8e02a5f6c72f8dd63156cfaa08606b14031ad95da1a3474e19c362e3611853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1546508576&rft_id=info:pmid/23884073&rft_jstor_id=23484004&rfr_iscdi=true |